COST-MINIMIZATION ANALYSIS OF DELAFLOXACIN VERSUS STANDARD OF CARE FOR THE TREATMENT OF ACUTE BACTERIAL SKIN AND SKIN STRUCTURE INFECTIONS (ABSSSI) IN JORDAN

被引：0
|
作者：
Naser, A. [1 ]
Bilbisi, M. [2 ]
Mousa, R. [3 ]
机构：
[1] Isra Univ, Amman, Jordan
[2] Abdali Med Ctr, Amman, Jordan
[3] Univ Jordan, Fac Pharm, Amman, Jordan
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE636
引用
收藏
页码：S175 / S175
页数：1
相关论文
共 50 条
  • [31] Antibiotic treatment of acute bacterial skin and skin structure infections
    Russo, Alessandro
    Vena, Antonio
    Bassetti, Matteo
    CURRENT OPINION IN INFECTIOUS DISEASES, 2022, 35 (02) : 120 - 127
  • [32] DEVELOPMENT OF A NEW PATIENT REPORTED OUTCOME (PRO) MEASURE FOR ACUTE BACTERIAL SKIN AND SKIN STRUCTURE INFECTIONS (ABSSSI)
    Powers, J. H.
    Siuciak, J. A.
    Llorens, L.
    Talbot, G. H.
    Crawley, J.
    Halling, K.
    Cimms, T. A.
    DeBusk, K.
    Howard, K.
    VALUE IN HEALTH, 2013, 16 (03) : A46 - A46
  • [33] Comparative efficacy of delafloxacin for complicated and acute bacterial skin and skin structure infections: results from a network meta-analysis
    Ioanna Vlachaki
    Matteo Vacchelli
    Daniela Zinzi
    Edel Falla
    Yilin Jiang
    Theo Mantopoulos
    Dilip Nathwani
    BMC Infectious Diseases, 21
  • [34] Comparative efficacy of delafloxacin for complicated and acute bacterial skin and skin structure infections: results from a network meta-analysis
    Vlachaki, Ioanna
    Vacchelli, Matteo
    Zinzi, Daniela
    Falla, Edel
    Jiang, Yilin
    Mantopoulos, Theo
    Nathwani, Dilip
    BMC INFECTIOUS DISEASES, 2021, 21 (01)
  • [35] The efficacy and adverse events of delafloxacin for treating acute bacterial skin and skin structure infections: A systematic review and meta-analysis
    Tanvir, Syed Bial
    Bin Qasim, Syed Saad
    Latimer, Joe
    Qamar, Zeeshan
    Niazi, Fayez Hussain
    JOURNAL OF PHARMACY AND BIOALLIED SCIENCES, 2020, 12 : 538 - 545
  • [36] Ceftaroline fosamil as first-line versus second-line treatment for acute bacterial skin and skin structure infections (ABSSSI) or community-acquired bacterial pneumonia (CABP)
    Guervil, David J.
    Kaye, Keith S.
    Hassoun, Ali
    Cole, Phillip
    Huang, Xing-Yue
    Friedland, H. David
    JOURNAL OF CHEMOTHERAPY, 2016, 28 (03) : 180 - 186
  • [37] Safety of Dalbavancin in the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI): Nephrotoxicity Rates Compared with Vancomycin: A Post Hoc Analysis of Three Clinical Trials
    Gonzalez, Pedro L.
    Rappo, Urania
    Mas Casullo, Veronica
    Akinapelli, Karthik
    McGregor, Jennifer S.
    Nelson, Jennifer
    Nowak, Michael
    Puttagunta, Sailaja
    Dunne, Michael W.
    INFECTIOUS DISEASES AND THERAPY, 2021, 10 (01) : 471 - 481
  • [38] USE OF DALBAVANCIN IN THE TREATMENT OF ACUTE BACTERIAL SKIN AND SKIN STRUCTURE INFECTIONS IN THE SPANISH HOSPITAL SETTING: A COMPARATIVE COST ANALYSIS
    Hernandez, I
    Carcedo, D.
    Sabaniego, J.
    Rossello, I
    Jimenez, A.
    VALUE IN HEALTH, 2022, 25 (12) : S188 - S188
  • [39] Novel developments in the treatment of acute bacterial skin and skin structure infections
    Jaffa, Rupal K.
    Pillinger, Kelly E.
    Roshdy, Danya
    Isip, Jacqueline A.
    Pasquale, Timothy R.
    EXPERT OPINION ON PHARMACOTHERAPY, 2019, 20 (12) : 1493 - 1502
  • [40] The safety of treatment options for acute bacterial skin and skin structure infections
    Bassetti, Matteo
    Peghin, Maddalena
    Castaldo, Nadia
    Giacobbe, Daniele Roberto
    EXPERT OPINION ON DRUG SAFETY, 2019, 18 (08) : 635 - 650
12345